패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Accolade, Inc. 23 애널리스트 중 14 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Matthew Gillmor	Baird
Zhilin Long	Berenberg
Allen Lutz	BofA Global Research

Accolade 대차 대조표 상태

재무 상태 기준 확인 5/6

주요 정보

최근 재무 상태 업데이트

Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?

Accolade, Inc. announced delayed annual 10-K filing

Recent updates

Accolade, Inc. to Report Q3, 2025 Results on Jan 09, 2025

Accolade: A GARP Stock Trading Well Under 1X Revenues

Consensus EPS estimates upgraded to US$0.93 loss

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Accolade, Inc. to Report Q2, 2025 Results on Oct 08, 2024

Accolade: Consider Both Short-Term Revenue Outlook And Rumored Takeover

Consensus EPS estimates upgraded to US$1.09 loss, revenue downgraded

Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Price target decreased by 34% to US$8.80

Accolade: Mixed Guidance (Rating Downgrade)

Accolade, Inc., Annual General Meeting, Aug 06, 2024

Accolade, Inc. to Report Q1, 2025 Results on Jun 27, 2024

Chairman of the Board & CEO exercised options and sold US$123k worth of stock

Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Price target decreased by 7.1% to US$14.00

Accolade: Staying Bullish On Favorable Developments

Accolade, Inc. to Report Q4, 2024 Results on Apr 25, 2024

Accolade, Inc. Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President

Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Accolade: Remain Confident That FY25 Guided Growth Is Achievable

Consensus EPS estimates upgraded to US$1.32 loss

Chairman of the Board & CEO notifies of intention to sell stock

Accolade: Turning Bullish After Beat-And-Raise Quarter (Rating Upgrade)

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ending February 29, 2024 and Year Ending February 28, 2025

Accolade, Inc. to Report Q3, 2024 Results on Jan 08, 2024

CFO & Treasurer exercised options to buy US$238k worth of stock.

Chairman of the Board & CEO exercised options to buy US$1.1m worth of stock.

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Accolade, Inc. to Report Q2, 2024 Results on Oct 04, 2023

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Accolade, Inc., Annual General Meeting, Aug 08, 2023

Accolade, Inc. to Report Q1, 2024 Results on Jun 29, 2023

Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Chairman of the Board & CEO exercised options to buy US$4.3m worth of stock.

Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

Price target increased by 8.9% to US$15.53

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 30% undervalued

Price target increased by 8.1% to US$14.27

Accolade, Inc. Announces Changes to Its Board of Directors

An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending February 28, 2023; Provides Earnings Guidance for the Year Ending February 29, 2024

Accolade, Inc. to Report Q3, 2023 Results on Jan 09, 2023

Price target increased to US$13.93

Accolade: Inching Closer To Profitability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Accolade, Inc. Provides Revenue Guidance for the Fiscal Third Quarter Ending November 30, 2022 and Fiscal Year Ending February 28, 2023

Accolade Q2 2023 Earnings Preview

Accolade, Inc. to Report Q2, 2023 Results on Oct 06, 2022

Price target increased to US$11.58

Accolade: Fair And Reasonably Priced, But Needs More Time

Chairman of the Board & CEO recently bought US$177k worth of stock

Accolade, Inc. Appoints Kelli Burns as Senior Vice President, Chief Information Security Officer

Accolade, Inc. Provides Earnings Guidance for Second Quarter Ending August 31, 2022 and Fiscal Year Ending February 28, 2023

Accolade Q1 2023 Earnings Preview

Accolade, Inc.(NasdaqGS:ACCD) dropped from Russell 2000 Growth Index

Accolade, Inc., Annual General Meeting, Jul 26, 2022

Accolade, Inc. to Report Q1, 2023 Results on Jun 30, 2022

Accolade, Inc. announced delayed annual 10-K filing

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to US$31.86

Accolade, Inc. to Report Q4, 2022 Results on Apr 28, 2022

Price target decreased to US$31.86

Accolade: Little Recent Applause

Price target decreased to US$33.92

Price target decreased to US$37.77

Consensus forecasts updated

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter, Fiscal Year Ending February 28, 2022 and Fiscal Year 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind